Drugs / Manuka honey
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT03399331 | Jul 2017 → Dec 2021 | chemotherapy-induced oral mucositis, leukemia | American University of Beirut Medical Center | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT02678104 | Oct 2016 → Jun 2017 | alveolar periostitis | Riyadh Colleges of Dentistry and Pharmacy | Unknown | No outcome recorded |
| Phase 2 | NCT01262560 | Feb 2012 → Feb 2014 | esophagitis, lung neoplasm | Radiation Therapy Oncology Group | Completed | No outcome recorded |
| Phase 2/32 trials | ||||||
| Phase 2/3 | NCT05657717 | Jul 2021 → Sep 2022 | chronic purulent otitis media, tympanic membrane disorder | Faculty of Medicine, University of Indonesia | Completed | No outcome recorded |
| Phase 2/3 | NCT05631600 | Sep 2017 → Sep 2018 | periodontitis | University of Zagreb | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06726876 | Oct 2024 → Dec 2025 overdue | periodontitis | Ain Shams University | Recruiting | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02483741 | Jun 2015 → May 2016 | impacted teeth, multiple | Damascus University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03862053 Comparator | Jan → Oct 2020 | conjunctivitis | Toyos Clinic | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Manuka Honey | “Efficacy of Manuka honey on severity and pain of OM compared to placebo (standard care) and to assess which of the two interventions is more beneficial.” NCT03399331 ↗7“The purpose of this clinical trial is to learn about the otological safety of 100% Medical grade Manuka Honey given to tympanoplasty patients” NCT05657717 ↗ “Active Ingredient: Manuka honey, known for its unique antibacterial properties due to high levels of methylglyoxal (MGO).” NCT06726876 ↗ |
| Action | Inhibit | “Manuka honey has been shown to inhibit a wide range of microorganisms” NCT02483741 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The use of honey for its medicinal properties dates back to 2200 BCE.” NCT05657717 ↗ |
| Route | Oral | “Patients swallow 10 cc (approximately 2 level teaspoons) of liquid Manuka honey” NCT01262560 ↗ |